司坦唑醇联合参芪扶正注射液治疗晚期肿瘤患者的疗效观察

目的观察蛋白同化激素司坦唑醇联合参芪扶正注射液治疗晚期恶性肿瘤患者的临床疗效。方法158例晚期恶性肿瘤患者随机分为对照组和治疗组各79例，对照组给予对症及支持治疗，治疗组在对照组的基础上应用司坦唑醇和参芪扶正注射液治疗。比较两组体质量、血液学、生化指标及karnofsky评分变化情况等。结果治疗组治疗后体质量改善有效率81．0％（64／79）、karnofsky评分增加有效率68．4％（54／79）、外周血白细胞计数、血小板计数、血红蛋白及血浆总蛋白含量均明显增加，谷丙转氨酶、谷草转氨酶明显减低，与对照组治疗后比较，差异均有统计学意义（均P〈0．01），未发生严重不良反应。结论司坦唑醇联合参芪扶正注射液能有效改善晚期肿瘤患者的生活质量。

Clinical observation on treatment of late stage cancer patients with stanozolol and shenqi injection

Objective To study the effect of stanozolol and shenqi injection used in comprehensive treatment of late stage cancer.Methods 158 late stage cancer patients,all treated only by rountine method and supportive treatment were randomly divided into 2 groups.And at the same time,79 patients in the treatment group were treated with stanozolol,2mg,po,tid,and shenqi injection 250ml,ivdrip,qd for nine weeks.All patients were recorded weight and hematology biochemical indicator.Results The treatment group surpasses the control group obviously (P＜0.01 ).Conclusion Stanozolol and shenqi injection can improve quality of life of late stage cancer patients and reduce dyscrasia syndrome.